|CUV -- Germany Stock|| |
EUR 0.44 0.011 2.46%
Mr. Darren M. Keamy, BComm, CPA, serves as Company Secretary and Chief Financial Officer of Clinuvel Pharmaceuticals Ltd. He is Certified Practicing Accountant, joined Clinuvel Pharmaceuticals Limited November 2005 and became Chief Financial Officer of the Company in 2006.
CFO Since 2006 CPA
852 3959 2888 http://www.realord.com.hk
The company has return on total asset (ROA)
of 0.07 %
which means that it generated profit of $0.07 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE)
of 11.11 %
meaning that it generated $11.11 on every $100 dollars invested by stockholders.
The company has accumulated 80.8 M in total debt with debt to equity ratio (D/E) of 57.4 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Realord Group Holdings Limited has Current Ratio of 1.4 which is within standard range for the sector.
Realord Group Holdings Limited, an investment holding company, engages in the commercial printing, hangtag, motor vehicles parts, financial service, trading, property investment, and environmental protection businesses in Hong Kong, Mainland China, and internationally. Realord Group Holdings Limited is a subsidiary of Manureen Holdings Limited. Realord Group operates under Auto Parts classification in Germany and traded on Frankfurt Stock Exchange. It employs 166 people.Realord Group Holdings Limited (CUV) is traded on Frankfurt Stock Exchange in Germany. It is located in Jardine House and employs 166 people.
Realord Group Holdings Leadership Team
|Willem Blijdorp, Non-Executive Director|
|Elie Ishag, Non-Executive Director|
|Stanley McLiesh, Non-Executive Chairman of the Board|
|Philippe Wolgen, CEO, Managing Director, Director|
|Darren Keamy, CFO, Company Secretary|
|Dennis Wright, Vice President - Scientific Affairs|
|Brenda Shanahan, Non-Executive Director|
Stock Performance Indicators